Cell and Gene Therapy Conference Review of Phase I and II ATIR101™ data – Business Wire (press release)
|
Cell and Gene Therapy Conference Review of Phase I and II ATIR101™ data
Business Wire (press release) Kiadis Pharma is focused on cell-based immunotherapy products, as an adjunctive to a haploidentical hematopoietic stem cell transplantation (HSCT), for the treatment of blood cancers and inherited blood disorders. The Company's product candidates have … |
